| Original language | English |
|---|---|
| Pages (from-to) | e139-e141 |
| Number of pages | 3 |
| Journal | Haematologica |
| Volume | 101 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Mar 31 2016 |
Keywords
- ABVD
- Brentuximab vedotin
- Early
- Hodgkin lymphoma
- Intermediate
- Radiotherapy
- Toxicity
ASJC Scopus subject areas
- Hematology
Cite this
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma : Final results of a pilot phase II study. / Federico, Massimo; Luminari, Stefano; Pellegrini, Cinzia; Merli, Francesco; Pesce, Emanuela Anna; Chauvie, Stephane; Gandolfi, Letizia; Capodanno, Isabella; Salati, Massimiliano; Argnani, Lisa; Zinzani, Pier Luigi.
In: Haematologica, Vol. 101, No. 4, 31.03.2016, p. e139-e141.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma
T2 - Final results of a pilot phase II study
AU - Federico, Massimo
AU - Luminari, Stefano
AU - Pellegrini, Cinzia
AU - Merli, Francesco
AU - Pesce, Emanuela Anna
AU - Chauvie, Stephane
AU - Gandolfi, Letizia
AU - Capodanno, Isabella
AU - Salati, Massimiliano
AU - Argnani, Lisa
AU - Zinzani, Pier Luigi
PY - 2016/3/31
Y1 - 2016/3/31
KW - ABVD
KW - Brentuximab vedotin
KW - Early
KW - Hodgkin lymphoma
KW - Intermediate
KW - Radiotherapy
KW - Toxicity
UR - http://www.scopus.com/inward/record.url?scp=84962343919&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84962343919&partnerID=8YFLogxK
U2 - 10.3324/haematol.2015.138388
DO - 10.3324/haematol.2015.138388
M3 - Article
AN - SCOPUS:84962343919
VL - 101
SP - e139-e141
JO - Haematologica
JF - Haematologica
SN - 0390-6078
IS - 4
ER -